Genolution
제놀루션 · 225220
Health Care Pharmaceuticals · KOSDAQ
Market cap US$21.6M (₩29.8B)
Overview
Genolution makes diagnostic tools that detect genetic material, such as DNA and RNA, from human samples like blood, urine, and swabs, enabling laboratories to identify infectious diseases, cancers, and hereditary conditions.
Its products include reagents that extract nucleic acids from samples and automated instruments that perform that extraction, supplied to clinical and research settings. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company runs two distinct business lines: molecular diagnostics devices and products and services related to RNAi (RNA interference, a gene-silencing research technique).
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$7.1M
- FY2024US$5.2M
- FY2025US$6.8M
Operating profit
- FY2023−US$5.1M
- FY2024−US$6.6M
- FY2025−US$6.3M
Net income
- FY2023−US$4M
- FY2024−US$5.2M
- FY2025−US$9.1M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?